[CLDX] YoY Quarter Result on 31-Mar-2012 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
04-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- -6.16%
YoY- -34.37%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
Revenue 486 416 2,414 2,433 2,516 3,713 3,732 -28.79%
PBT -30,174 -29,903 -17,332 -13,083 -9,574 -6,245 -7,704 25.53%
Tax -1,614 -1,586 -379 -410 -268 -6,324 -165 46.21%
NP -30,174 -29,903 -17,332 -13,516 -10,059 -6,582 -7,704 25.53%
Tax Rate - - - - - - - -
Total Cost 30,660 30,319 19,746 15,949 12,575 10,295 11,436 17.85%
Ratio Analysis
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
NP Margin -6,208.64 -7,188.22 -717.98 -555.53 -399.80 -177.27 -206.45 76.29%
Per Share
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
EPS -4.90 -5.02 -3.51 -4.04 -4.71 -3.11 -7.30 -6.42%
EPS Diluted -4.90 -5.02 -3.51 -4.04 -4.71 -3.11 -7.30 -6.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.